AGENT WITH NEUROPROTECTIVE ANTI-ISCHEMIC ACTIVITY Russian patent published in 2022 - IPC A61K31/05 A61K31/4164 A61P9/10 

Abstract RU 2780112 C1

FIELD: anti-ischemic agents.

SUBSTANCE: invention relates to the use of salicyl-beta-alanyl-L-histidine (salicyl-carnosine) as a neuroprotective anti-ischemic agent in the form of the viability of neurons in a primary culture of rat cerebral cortex cells under conditions of glucose-oxygen deprivation and in a model of NMDA-induced excitotoxicity.

EFFECT: invention provides the ability to use salicyl-beta-alanyl-L-histidine (salicyl-carnosine) as a neuroprotective anti-ischemic agent.

1 cl, 5 dwg, 3 ex

Similar patents RU2780112C1

Title Year Author Number
REMEDY WITH ANTIOXIDANT AND NEUROPROTECTIVE ACTIVITY 2021
  • Fedorova Tatyana Nikolaevna
  • Stvolinskij Sergej Lejbovich
  • Migulin Vasilij Andreevich
  • Lopachev Aleksandr Vasilevich
  • Khutorova Anastasiya Viktorovna
  • Kulikova Olga Igorevna
  • Muzychuk Olga Andreevna
  • Abaimov Denis Aleksandrovich
RU2777391C1
AGENT POSSESSING ANTIAGGREGANT, CYTOPROTECTIVE AND ANTIOXIDANT ACTIVITY 2018
  • Tanashyan Marine Movsesovna
  • Fedorova Tatyana Nikolaevna
  • Stvolinskij Sergej Lejbovich
  • Andreeva Lyudmila Aleksandrovna
  • Nagaev Igor Yulianovich
  • Migulin Vasilij Andreevich
  • Shabalina Alla Anatolevna
  • Trubitsyna Irina Evgenevna
  • Lopachev Aleksandr Vasilevich
  • Kulikova Olga Igorevna
  • Abaimov Denis Aleksandrovich
RU2694061C1
METHOD FOR EVALUATING THE BIOLOGICAL ACTIVITY OF A TETRADECAPEPTIDE 2017
  • Chulkina Marina Mikhajlovna
  • Lebedeva Ekaterina Semenovna
  • Pichugin Aleksej Vasilevich
  • Kholmukhamedov Ekhson Lukmanovich
  • Ataullakhanov Ravshan Inoyatovich
  • Dudchenko Aleksandr Maksimovich
RU2667120C1
METHOD FOR ACHIEVING DESIRED GLIAL GROWTH FACTOR 2 PLASMA LEVELS 2014
  • Kim Khaesun
  • Kadzhano Entoni O.
RU2687097C2
3R,4S 3-[4-(4-FLUOROPHENYL)-4-HYDROXYPIPERIDIN-1- YL)CHROHAN-4,7-DIOL, OPTICAL ISOMERS THEREOF AND PHARMACEUTICAL COMPOSITION BASED THEREON, AND METHOD OF MEDICAL TREATMENT 1994
  • Todd V.Batler
  • Bertrand L.Chenard
RU2126404C1
METHOD OF PROVIDING REQUIRED LEVELS OF GLIAL GROWTH FACTOR 2 IN PLASMA 2009
  • Kim Khaesun
  • Kadzhano Ehntoni O.
RU2530650C2
CARDIOTROFIN APPLICATION IN LIVER DISEASES 2002
  • Bustos De Abakho Matil'De
  • Prieto Valtuehn'Ja Khesus
  • Lasarte Sagastibel'Sa Khuan Khose
  • Bajkseras L'Jano Ehlena
RU2279289C2
METHOD FOR PREVENTING AND CORRECTING METABOLIC AND FUNCTIONAL DISORDERS OF THE CENTRAL NERVOUS SYSTEM UNDER STRESS CONDITIONS 2019
  • Kozin Stanislav Vladimirovich
  • Kravtsov Aleksandr Anatolevich
  • Zlishcheva Enna Ivanovna
  • Shurygina Lyudmila Vasilevna
  • Lomakina Larisa Vladimirovna
  • Dzhimak Stepan Sergeevich
  • Baryshev Mikhail Gennadevich
  • Basov Aleksandr Aleksandrovich
RU2717107C1
NEUROPROTECTIVE AGENT 2016
  • Rastashanskij Vyacheslav Valerievich
  • Ostrenko Konstantin Sergeevich
  • Gromova Olga Alekseevna
RU2614697C1
THERAPEUTIC COMPOSITION FOR REDUCING RESISTANCE TO TYROSINE KINASE INHIBITORS 2016
  • D'Hondt, Erik
  • Molina Vila, Miguel, Angel
RU2735493C2

RU 2 780 112 C1

Authors

Stvolinskii Sergei Leibovich

Fedorova Tatiana Nikolaevna

Khutorova Anastasiia Viktorovna

Lopachev Aleksandr Vasilevich

Timoshina Iuliia Alekseevna

Kulikova Olga Igorevna

Tanashian Marine Movsesovna

Dates

2022-09-19Published

2022-02-18Filed